title: Possible prevention of fulminant hepatic failure in four children with acute severe hepatitis.
authors.forename: Makoto
authors.initials: M
authors.lastname: Yoshiba
authors.forename: Masaya
authors.initials: M
authors.lastname: Yamada
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Inoue
authors.forename: Tsunamasa
authors.initials: T
authors.lastname: Watanabe
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kanesaka
authors.forename: Keiichi
authors.initials: K
authors.lastname: Isoyama
mesh_terms: D000293:Adolescent; D000998:Antiviral Agents / Q000008:administration & dosage*; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007372:Interferons / Q000008:administration & dosage*; D017093:Liver Failure / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D007372:Interferons; D008775:Methylprednisolone